Because 11β-HSD2 can be deficient in low-renin hypertensives, genetic testing of HSD11B2 is required to screen for AME, especially in patients with a clinical history or increased cortisol to cortisone ratios [32]. The gene discussed is HSD11B2; the disease is apparent mineralocorticoid excess.